Anti-inflammatory effects of OBA-09, a salicylic acid/pyruvate ester, in the postischemic brain

Brain Research

Volumn 1528, Issue , 2013, Pages 68-79

  Lee, Hye Kyung ^a   Kim, Seung Woo ^a   Jin, Yinchuan ^a   Kim, Il Doo ^a   Park, Ju Young ^b   Yoon, Sung Hwa ^b   Lee, Ja Kyeong ^a  

^a Inha University School of Medicine   (South Korea)

^b Ajou University   (South Korea)

Author keywords

Anti inflammation; MCAO; OBA 09; Pyruvate; Salicylic acid

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; OBA 09; SALICYLIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPROTECTIVE AGENT; OXYPROPANOYLOXY BENZOIC ACID; PYRUVIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; CEREBRAL ARTERY DISEASE; DRUG EFFECTS; MALE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CYTOKINES; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICROGLIA; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; SALICYLATES;

EID: 84882272279     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.06.026     Document Type: Article

References (45)

1. D. Amantea, G. Nappi, G. Bernardi, G. Bagetta, and M.T. Corasaniti Postischemic brain damage: pathophysiology and role of inflammatory mediators FEBS J. 276 2009 13 26
2. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Br. Med. J. 324 2002 71 86
3. M.M. Bednar, S. Raymond, T. McAuliffe, P.A. Lodge, and C.E. Gross The role of neutrophils and platelets in a rabbit model of thromboembolic stroke Stroke 22 1991 44 50
4. K.M. Boje, and P.K. Arora Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death Brain Res. 587 1992 250 256
5. J. Castillo, R. Leira, M.A. Moro, I. Lizasoain, J. Serena, and A. Dávalos Neuroprotective effects of aspirin in patients with acute cerebral infarction Neurosci. Lett. 339 2003 248 250
6. C.A. Colton, and D.L. Gilbert Production of superoxide anions by a CNS macrophage, the microglia FEBS Lett. 223 1987 284 288
7. S. Desagher, J. Glowinski, and J. Prémont Pyruvate protects neurons against hydrogen peroxide-induced toxicity J. Neurosci. 17 1997 9060 9067
8. J. De Cristóbal, M.A. Moro, A. Dávalos, J. Castillo, J.C. Leza, J. Camarero, M.I. Colado, P Lorenzo, and I. Lizasoain Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats J. Neurochem. 79 2001 456 459
9. D.L. DeWitt, E.A. el-Harith, S.A. Kraemer, M.J. Andrews, E.F. Yao, R.L. Armstrong, and W.L. Smith The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases J. Biol. Chem. 265 1990 5192 5198
10. P. Dobsak, C. Courderot-Masuyer, M. Zeller, C. Vergely, A. Laubriet, M. Assem, J.C. Eicher, J.R. Teyssier, J.E. Wolf, and L. Rochette Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia J. Cardiovasc. Pharmacol. 34 1999 651 659
11. U. Dirnagl, C. Iadecola, and M.A. Moskowitz Pathobiology of ischaemic stroke: an integrated view Trends Neurosci. 22 1999 391 397
12. S.H. Graham, and J. Chen Programmed cell death in cerebral ischemia J. Creb. Blood Flow Metab 21 2001 99 109
13. J.M. Hallenbeck, A.J. Dutka, T. Tanishima, P.M. Kochanek, K.K. Kumaroo, C.B. Thompson, T.P. Obrenovitch, and T.J. Contreras Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period Stroke 17 1986 246 253
14. Y. Han, J.A. Englert, R. Yang, R.L. Delude, and M.P. Fink Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65 Pharmacol. Rev. 312 2005 1097 1105
15. G.A. Higgs, J.A. Salmon, B. Henderson, and J.R. Vane Pharmacokinetics of aspirin and salicylate in relation of inhibition of arachidonate cyclooxygenase and anti-inflammatory activity Proc. Natl. Acad. Sci. USA 84 1987 1417 1420
16. Y. Imai, I. Ibata, D. Ito, K. Ohsawa, and S. Kohsaka A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage Biochem. Biophys. Res. Commun. 224 1996 855 862
17. J.B. Kim, Y.M. Yu, S.W. Kim, and J.K. Lee Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain Brain Res. 1060 2005 188 192
18. Kim, J.B., Lim, C.M., Yu, Y.M., Lee J.K., 2008. Induction and subcellular localization of high mobility group box-1 (HMGB1) in the postischemic brain, J. Neurosci. Res. 86, 1125-1131.
19. S.W. Kim, J.Y. Jeong, H.J. Kim, J.S. Seo, P.L. Han, S.H. Yoon, and J.K. Lee Combination Treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain Neurotoxicity Res. 17 2010 39 49
20. S.W. Kim, H.J. Kim, J.H. Shin, I.D. Kim, J.E. Lee, P.L. Han, S.H. Yoon, and J.K. Lee Robust protective effects of a novel multimodal neuroprotectant oxopropanoyloxy benzoic acid, a salicylic acid/pyruvate ester, in the postischemic brain Mol. Pharmacol. 79 2011 220 228
21. J.B. Kim, J.S. Choi, Y.M. Yu, K. Nam, C.S. Piao, S.W. Kim, M.H. Lee, P.L. Han, J.S. Park, and JK. Lee HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain J Neurosci. 26 2006 6413 6421
22. T. Kirino Delayed neuronal death Neuropathology 20 2000 S95 S97
23. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 1994 956 959
24. M. Lalancette-Hébert, G. Gowing, A. Simard, Y.C. Weng, and J. Kriz Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain J. Neurosci. 27 2007 2596 2605
25. J.Y. Lee, Y.H. Kim, and J.Y. Koh Protection by pyruvate against transient forebrain ischemia in rats J. Neurosci. 21 2001 71 RC1 2001 71
26. P. Lipton Ischemic cell death in brain neurons Physiol. Rev. 79 1999 1431 1568
27. T. Morioka, A.N. Kalehua, and W.J. Streit Characterization of microglial reaction after middle cerebral artery occlusion in rat brain J. Comp. Neurol. 327 1993 123 132
28. K.W. Muir, P. Tyrrell, N. Sattar, and E. Warburton Inflammation and ischaemic stroke Curr. Opin. Neurol. 20 2007 334 342
29. R.J. Mullen, C.R. Buck, and A.M. Smith NeuN, a neuronal specific nuclear protein in vertebrates Development 116 1992 201 211
30. J. O'Donnell-Tormey, C.F. Nathan, K. Lanks, C.J. DeBoer, and J. de la Harpe Secretion of pyruvate. An antioxidant defense of mammalian cells J. Exp. Med. 165 1987 500 514
31. P. Pesheva, S. Ursche, K. Frei, and R. Probstmeier Murine microglial cells express functionally active galectin-3 in vitro J. Neurosci. 51 1998 49 57
32. P.G. Rausch, K.B. Pryzwansky, J.K. Spitznagel, and J.C. Herion Immunocytochemical identification of abnormal polymorphonuclear neutrophils in patients with leukemia Blood Cells 4 1978 369 382
33. G.J. Roth, N. Stanford, and P.W. Majerus Acetylation of prostaglandin synthase by aspirin Proc. Natl. Acad. Sci. USA 72 1975 3073 3076
34. M.G. Ryou, R. Liu, M. Ren, J. Sun, R.T. Mallet, and S.H. Yang Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathway Stroke 43 2012 1101 1107
35. M. Sawada, N. Kondo, A. Suzumura, and T. Marunouchi Production of tumor necrosis factor-alpha by microglia and astrocytes in culture Brain Res. 491 1989 394 397
36. C.T. Sheline, M.M. Behrens, and D.W. Choi Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD1 and inhibition of glycolysis J. Neurosci. 20 2000 3139 3146
37. J.B. Smith, and A.L. Willis Aspirin selectively inhibits prostaglandin production in human platelets Nature 231 1971 235 237
38. J.A. Smitha, D. Arabinda, S.K. Rayb, and N.L. Banika Role of proinflammatory cytokines released from microglia in neurodegenerative diseases Brain Res. Bull. 87 2012 10 20
39. M. Tomita, and Y. Fukuuchi Leukocytes, macrophages and secondary brain damage following cerebral ischemia Acta Neurochir. Suppl. 66 1996 32 39
40. Q. Wang, M. van Hoecke, X.N. Tang, H. Lee, Z. Zheng, R.A. Swanson, and M.A. Yenari Pyruvate protects against experimental stroke via an anti-inflammatory mechanism Neurobiol. Dis. 36 2009 223 231
41. X.-M. Xu, L. Sansores-Garcia, X.-M. Chen, N. Matijevic-Aleksic, M. Du, and K.K. Wu Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate Proc. Natl. Acad. Sci. USA 96 1999 5292 5297
42. M.J. Yin, Y. Yamamoto, and R.B. Gaynor The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinasebeta Nature 396 1998 77 80
43. J. Yrjanheikki, R. Keinanen, M. Pellikka, T. Hokfelt, and J. Koistinaho Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia Proc. Natl. Acad. Sci. USA 95 1998 15769 15774
44. Y.M. Yu, J.B. Kim, K.W. Lee, S.Y. Kim, P.L. Han, and J.K. Lee Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window Stroke 36 2005 2238 2243
45. R. Zhang, M. Chopp, Z. Zhang, N. Jiang, and C. Powers The expression of P- and E-selectins in three models of middle cerebral artery occlusion Brain Res. 785 1998 207 214